Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors inside the central nervous procedure, conolidine modulates alternate molecular targets. A Science Advances study identified that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availa... https://epicurusc420cdf1.blogrenanda.com/profile